Key Findings
No summary available
Ivermectin as an Effective Treatment for Covid-19
phillyharper
•
6 months ago
•
Public Case
This case examines the potential effectiveness of Ivermectin as a treatment for Covid-19, exploring various studies and literature that either support or dispute this claim.
Supporting Evidence
22 studies
Academic Study
Covid 19 and Ivermectin Prevention and Treatment Update
Key Findings
No summary available
Academic Study
Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients
Key Findings
No summary available
Academic Study
Effectiveness of ivermectin for COVID-19: A systematic review
Key Findings
No summary available
Academic Study
Ivermectin for preventing and treating COVID‐19 - Popp, M - 2021
Key Findings
No summary available
Academic Study
Is Ivermectin Effective in Treating COVID-19?
Key Findings
No summary available
Key Findings
No summary available
Key Findings
No summary available
Key Findings
No summary available
Key Findings
No summary available
Academic Study
Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin
Key Findings
No summary available
Key Findings
No summary available
Key Findings
No summary available
Academic Study
Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (Pilot Trial)
Key Findings
No summary available
Academic Study
Ivermectin for preventing and treating COVID‐19 - Popp, M - 2021
Key Findings
No summary available
Academic Study
COVID-19: Ivermectin; Molecular Mechanisms, Limitations, Suggestions - Bezmialem Science
Key Findings
No summary available
Academic Study
The pharmacokinetic rationale of Ivermectin for COVID-19 therapy.
Key Findings
No summary available
Academic Study
Effectiveness of Ivermectin among COVID-19 patients: A Randomized Controlled Trial
Key Findings
Summary:
A randomized controlled trial conducted at Holy Family Hospital Rawalpindi assessed the effectiveness of Ivermectin in treating COVID-19 patients. The study involved 90 PCR positive patients, divided into an experimental group receiving standard care plus Ivermectin and a control group receiving only standard care. Key findings included a significantly shorter time to PCR negativity (P=0.002) and improvements in Clinical Severity Score (P=0.02), hemoglobin levels (P=0.03), and platelet
Academic Study
Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients
Key Findings
No summary available
Academic Study
Effectiveness of Ivermectin-Based Multidrug Therapy in Severe Hypoxic Ambulatory COVID-19 Patients
Key Findings
No summary available
Key Findings
No summary available
Key Findings
No summary available